AU2002224791A1 - Benzoxazinone derivatives, their preparation and use - Google Patents

Benzoxazinone derivatives, their preparation and use

Info

Publication number
AU2002224791A1
AU2002224791A1 AU2002224791A AU2479102A AU2002224791A1 AU 2002224791 A1 AU2002224791 A1 AU 2002224791A1 AU 2002224791 A AU2002224791 A AU 2002224791A AU 2479102 A AU2479102 A AU 2479102A AU 2002224791 A1 AU2002224791 A1 AU 2002224791A1
Authority
AU
Australia
Prior art keywords
methyl
benzo
oxazin
piperidinyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224791A
Other languages
English (en)
Inventor
Christopher Norbert Johnson
Harshad Kantilal Rami
Geoffrey Stemp
Kevin Thewlis
Mervyn Thompson
Antonio Kuok Keong Vong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026224A external-priority patent/GB0026224D0/en
Priority claimed from GB0111858A external-priority patent/GB0111858D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2002224791A1 publication Critical patent/AU2002224791A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU2002224791A 2000-10-26 2001-10-22 Benzoxazinone derivatives, their preparation and use Abandoned AU2002224791A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0026224A GB0026224D0 (en) 2000-10-26 2000-10-26 Novel compounds
GB0026224 2000-10-26
GB0111858A GB0111858D0 (en) 2001-05-15 2001-05-15 Novel compounds
GB0111858 2001-05-15
PCT/EP2001/012344 WO2002034754A2 (fr) 2000-10-26 2001-10-22 Derives de benzoxazinone, leur preparation et utilisation

Publications (1)

Publication Number Publication Date
AU2002224791A1 true AU2002224791A1 (en) 2002-05-06

Family

ID=26245199

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224791A Abandoned AU2002224791A1 (en) 2000-10-26 2001-10-22 Benzoxazinone derivatives, their preparation and use

Country Status (20)

Country Link
US (1) US6939871B2 (fr)
EP (1) EP1330460B1 (fr)
JP (1) JP4242643B2 (fr)
KR (1) KR20030051747A (fr)
CN (1) CN1478092A (fr)
AR (1) AR034174A1 (fr)
AT (1) ATE357448T1 (fr)
AU (1) AU2002224791A1 (fr)
BR (1) BR0114881A (fr)
CA (1) CA2426706A1 (fr)
CZ (1) CZ20031163A3 (fr)
DE (1) DE60127434T2 (fr)
ES (1) ES2280417T3 (fr)
HU (1) HUP0301458A2 (fr)
IL (1) IL155520A0 (fr)
MX (1) MXPA03003820A (fr)
NO (1) NO20031838L (fr)
PL (1) PL366378A1 (fr)
TW (1) TWI237023B (fr)
WO (1) WO2002034754A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203778D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203811D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
EP1546145A1 (fr) * 2002-09-26 2005-06-29 Warner-Lambert Company Llc Piperazines substituees heterocycliques destinees au traitement de la schizophrenie
AU2003301414B8 (en) 2002-10-10 2010-06-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Novel compounds with antibacterial activity
NZ539508A (en) 2002-11-08 2007-05-31 Hoffmann La Roche Substituted benzoxazinones and uses thereof
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
BRPI0409685A (pt) * 2003-04-30 2006-04-18 Fmc Corp derivados cìclicos fenil-substituìdos
GB0310849D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0310851D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
JP2008508314A (ja) * 2004-07-28 2008-03-21 アイアールエム・リミテッド・ライアビリティ・カンパニー ステロイドホルモン核内受容体のモジュレーターとしての化合物および組成物
RU2008118422A (ru) * 2005-10-13 2009-11-20 Морфохем Акциенгезельшафт Фюр Комбинаторише Хеми (De) Производные 5-хинолина, обладающие антибактериальной активностью
WO2010084152A1 (fr) 2009-01-21 2010-07-29 Basilea Pharmaceutica Ag Nouveaux antibiotiques bicycliques
BR112012014519A8 (pt) 2009-12-18 2017-12-26 Basilea Pharmaceutica Ag antibióticos tricíclicos
CN103635474B (zh) 2011-06-17 2016-04-27 巴斯利尔药物股份公司 三环抗生素
TW202244048A (zh) 2017-03-20 2022-11-16 美商佛瑪治療公司 作為丙酮酸激酶（ｐｋｒ）活化劑之吡咯并吡咯組成物
EP3853206B1 (fr) 2018-09-19 2024-04-10 Novo Nordisk Health Care AG Traitement de la drépanocytose avec un composé activant la pyruvate kinase r
CN113226356A (zh) 2018-09-19 2021-08-06 福马治疗股份有限公司 活化丙酮酸激酶r

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0906294T3 (da) 1996-05-29 2003-05-05 Warner Lambert Co Benzoxazinon-dopamin D4-receptor-antagonister
EP0900792B1 (fr) * 1997-09-02 2003-10-29 Duphar International Research B.V Dérivés de pipéridine et de pipérazine comme agonistes du récepteur 5-HT1
TW546299B (en) * 1999-01-07 2003-08-11 Wyeth Corp 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines
WO2000040581A1 (fr) * 1999-01-07 2000-07-13 American Home Products Corporation Derives de la 3,4-dihydro-2h benzo[1,4]oxazine

Also Published As

Publication number Publication date
WO2002034754A3 (fr) 2002-07-11
ATE357448T1 (de) 2007-04-15
CZ20031163A3 (cs) 2004-04-14
ES2280417T3 (es) 2007-09-16
PL366378A1 (en) 2005-01-24
TWI237023B (en) 2005-08-01
NO20031838D0 (no) 2003-04-24
IL155520A0 (en) 2003-11-23
BR0114881A (pt) 2003-09-30
DE60127434D1 (de) 2007-05-03
DE60127434T2 (de) 2007-11-29
HUP0301458A2 (hu) 2003-10-28
KR20030051747A (ko) 2003-06-25
CN1478092A (zh) 2004-02-25
NO20031838L (no) 2003-06-24
US20040063704A1 (en) 2004-04-01
US6939871B2 (en) 2005-09-06
EP1330460B1 (fr) 2007-03-21
CA2426706A1 (fr) 2002-05-02
AR034174A1 (es) 2004-02-04
JP2004516250A (ja) 2004-06-03
EP1330460A2 (fr) 2003-07-30
JP4242643B2 (ja) 2009-03-25
WO2002034754A2 (fr) 2002-05-02
MXPA03003820A (es) 2003-07-28

Similar Documents

Publication Publication Date Title
US6939871B2 (en) Benzoxazinone derivatives, their preparation and use
US20090076274A1 (en) Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
KR100799134B1 (ko) 페녹시프로필아민 화합물
KR100875558B1 (ko) 벤즈이미다졸론 카복실산 유도체
JP2009256363A (ja) ５−ｈｔ２ａ拮抗剤としてのオキサゾリジン類
US20040132720A1 (en) Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
US7244726B2 (en) Heterocyclic compounds possessing affinity at 5HT1 -type receptors and use thereof in therapy
US20040267010A1 (en) Sulfonamide compounds, their preparation and use
CA2184052A1 (fr) Piperidinylmethyloxazolidinones
EP1480972B1 (fr) Composes presentant une affinite vis-a-vis des recepteurs du type 5ht1, et leur utilisation dans des traitements des troubles du snc
US7214674B2 (en) Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
WO2003091248A1 (fr) Derive de benzoxazinone
WO2004099198A1 (fr) Derives de benzoxazinone possedant une affinite avec des recepteurs 5-ht, preparation et utilisation de ceux-ci